These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33797778)

  • 1. Adolescents and Drug Development: Commentary on a Dawning Paradigm Shift.
    Kearns GL; van den Anker JN
    J Clin Pharmacol; 2021 Jun; 61(6):740-743. PubMed ID: 33797778
    [No Abstract]   [Full Text] [Related]  

  • 2. Minors and a Dawning Paradigm Shift in "Pediatric" Drug Development.
    Rose K; Tanjinatus O; Grant-Kels JM; Ettienne EB; Striano P; Neubauer D
    J Clin Pharmacol; 2021 Jun; 61(6):736-739. PubMed ID: 33368372
    [No Abstract]   [Full Text] [Related]  

  • 3. A Call for Objective Dose Selection to Increase Success in Pediatric Clinical Trials: A Perspective From NICHD and NIMH Program Staff.
    Giacoia G; Grabb MC; Pawlyk AC; Ren Z; Samedy-Bates L; Taylor-Zapata P
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S9-S12. PubMed ID: 34185908
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress in Drug Development-Pediatric Dose Selection: Workshop Summary.
    Wang J; van den Anker JN; Burckart GJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S13-S21. PubMed ID: 34185909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-Informed Drug Development: A Regulatory Perspective on Progress.
    Zhu H; Huang SM; Madabushi R; Strauss DG; Wang Y; Zineh I
    Clin Pharmacol Ther; 2019 Jul; 106(1):91-93. PubMed ID: 31162631
    [No Abstract]   [Full Text] [Related]  

  • 6. Promoting Pediatric Drug Research and Labeling - Outcomes of Legislation.
    Bourgeois FT; Kesselheim AS
    N Engl J Med; 2019 Aug; 381(9):875-881. PubMed ID: 31461599
    [No Abstract]   [Full Text] [Related]  

  • 7. Developing Pharmacologic Treatments for Eosinophilic Esophagitis: Draft Guidance from the United States Food and Drug Administration.
    Lyons E; Donohue K; Lee JJ
    Gastroenterology; 2019 Aug; 157(2):275-277. PubMed ID: 31022402
    [No Abstract]   [Full Text] [Related]  

  • 8. [Not Available].
    Mentzer D
    Drug Res (Stuttg); 2018 Nov; 68(S 01):S19-S20. PubMed ID: 30453370
    [No Abstract]   [Full Text] [Related]  

  • 9. Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
    Loomba R; Ratziu V; Harrison SA;
    Gastroenterology; 2022 Mar; 162(3):680-688. PubMed ID: 34822801
    [No Abstract]   [Full Text] [Related]  

  • 10. [Not Available].
    Dötsch J; Endres S
    Drug Res (Stuttg); 2018 Nov; 68(S 01):S2. PubMed ID: 30453359
    [No Abstract]   [Full Text] [Related]  

  • 11. Puppies on the doorstep.
    Kline JA
    Acad Emerg Med; 2015 Mar; 22(3):354-6. PubMed ID: 25715775
    [No Abstract]   [Full Text] [Related]  

  • 12. The coronavirus outbreak could make it quicker and easier to trial drugs.
    Ledford H
    Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Precision Medicine on Efficiencies of Novel Drug Development in Cancer.
    Sarvas H; Carlisle B; Dolter S; Vinarov E; Kimmelman J
    J Natl Cancer Inst; 2020 Aug; 112(8):859-862. PubMed ID: 31722417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing a New Tuskegee: Food and Drug Administration Oversight of Overseas Research Must Match That in the United States.
    White CM; White LR
    J Clin Pharmacol; 2022 Mar; 62(3):434-437. PubMed ID: 34592028
    [No Abstract]   [Full Text] [Related]  

  • 15. European & Developing Countries Clinical Trials Partnership (EDCTP).
    Olesen OF
    Hum Vaccin Immunother; 2018 Jan; 14(1):14-16. PubMed ID: 29136388
    [No Abstract]   [Full Text] [Related]  

  • 16. Tiny and Forgotten: A Call for Focused Neonatal Policy Reform.
    Bucci-Rechtweg CM; Ward RM
    Ther Innov Regul Sci; 2019 Sep; 53(5):615-617. PubMed ID: 30621453
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA oversight of cell therapy clinical trials.
    Au P; Hursh DA; Lim A; Moos MC; Oh SS; Schneider BS; Witten CM
    Sci Transl Med; 2012 Aug; 4(149):149fs31. PubMed ID: 22932219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European Medicines Agency Experience With Pediatric Dose Selection.
    Manolis E; Musuamba FT; Karlsson KE
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S22-S27. PubMed ID: 34185894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA penalizes trial misconduct.
    Shaffer C
    Nat Biotechnol; 2009 Oct; 27(10):872. PubMed ID: 19816424
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent US Food and Drug Administration Efforts to Integrate the Patient's Perspective in Drug Development and Decision Making.
    Mullin T; Vaidya P; Chalasani M
    Clin Pharmacol Ther; 2019 Apr; 105(4):789-791. PubMed ID: 30609017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.